Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment
Status:
Completed
Trial end date:
2017-05-15
Target enrollment:
Participant gender:
Summary
To examine antihypertensive effect and safety of administration of CS-3150 in combination
with ARB or ACE inhibitor in hypertensive patients with moderate renal impairment.